APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gene-based Advanced Therapy Medical Product

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gene-based Advanced Therapy Medical Product Industry Growth and Trends Forecast to 2032

Report ID 17399457012 January 2026103 pages

Choose your research edition.

Industry ResearchGene-based Advanced Therapy Medical Product Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene-based Advanced Therapy Medical Product Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gene-based Advanced Therapy Medical Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene-based Advanced Therapy Medical Product Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene-based Advanced Therapy Medical Product Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Gene-based Advanced Therapy Medical Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gene-based Advanced Therapy Medical Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gene-based Advanced Therapy Medical Product is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene-based Advanced Therapy Medical Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Gene-based Advanced Therapy Medical Product market include Novartis, Amgen, Sunway Biotech, Spark Therapeutics, SIBIONO, Sarepta Therapeutics, Orchard Therapeutics, Human Stem Cells Institute and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gene-based Advanced Therapy Medical Product market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gene-based Advanced Therapy Medical Product market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene-based Advanced Therapy Medical Product market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene-based Advanced Therapy Medical Product.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Gene-based Advanced Therapy Medical Product market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gene-based Advanced Therapy Medical Product Market by Company

Novartis

Amgen

Sunway Biotech

Spark Therapeutics

SIBIONO

Sarepta Therapeutics

Orchard Therapeutics

Human Stem Cells Institute

Gilead Sciences

bluebird bio

Biogen

AnGes

Alnylam Pharmaceuticals

Akcea Therapeutics

Gene-based Advanced Therapy Medical Product Segment by Type

Viral Gene Delivery System

Non-viral Gene Delivery System

Gene-based Advanced Therapy Medical Product Segment by Application

Neurological Diseases

Cancer

Other

Gene-based Advanced Therapy Medical Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene-based Advanced Therapy Medical Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene-based Advanced Therapy Medical Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene-based Advanced Therapy Medical Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Gene-based Advanced Therapy Medical Product companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Gene-based Advanced Therapy Medical Product Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Gene-based Advanced Therapy Medical Product Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2021-2026) Table 4. Global Gene-based Advanced Therapy Medical Product Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2027-2032) Table 6. Global Gene-based Advanced Therapy Medical Product Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gene-based Advanced Therapy Medical Product Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2026) Table 9. Global Gene-based Advanced Therapy Medical Product Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Gene-based Advanced Therapy Medical Product Market Size Share Forecasted by Type (2027-2032) Table 11. North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2026) Table 24. Global Gene-based Advanced Therapy Medical Product Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Gene-based Advanced Therapy Medical Product Market Size Share Forecasted by Application (2027-2032) Table 26. North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Gene-based Advanced Therapy Medical Product Industry Trends Table 37. Gene-based Advanced Therapy Medical Product Industry Drivers Table 38. Gene-based Advanced Therapy Medical Product Industry Opportunities and Challenges Table 39. Gene-based Advanced Therapy Medical Product Industry Restraints Table 40. Global Gene-based Advanced Therapy Medical Product Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Company (2021-2026) Table 42. Global Gene-based Advanced Therapy Medical Product Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Gene-based Advanced Therapy Medical Product Key Company Headquarters & Area Served Table 44. Global Gene-based Advanced Therapy Medical Product Company, Product Type & Application Table 45. Global Gene-based Advanced Therapy Medical Product Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Gene-based Advanced Therapy Medical Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Gene-based Advanced Therapy Medical Product Product Portfolio Table 52. Novartis Recent Development Table 53. Amgen Company Information Table 54. Amgen Business Overview Table 55. Amgen Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Amgen Gene-based Advanced Therapy Medical Product Product Portfolio Table 57. Amgen Recent Development Table 58. Sunway Biotech Company Information Table 59. Sunway Biotech Business Overview Table 60. Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sunway Biotech Gene-based Advanced Therapy Medical Product Product Portfolio Table 62. Sunway Biotech Recent Development Table 63. Spark Therapeutics Company Information Table 64. Spark Therapeutics Business Overview Table 65. Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Spark Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio Table 67. Spark Therapeutics Recent Development Table 68. SIBIONO Company Information Table 69. SIBIONO Business Overview Table 70. SIBIONO Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. SIBIONO Gene-based Advanced Therapy Medical Product Product Portfolio Table 72. SIBIONO Recent Development Table 73. Sarepta Therapeutics Company Information Table 74. Sarepta Therapeutics Business Overview Table 75. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio Table 77. Sarepta Therapeutics Recent Development Table 78. Orchard Therapeutics Company Information Table 79. Orchard Therapeutics Business Overview Table 80. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio Table 82. Orchard Therapeutics Recent Development Table 83. Human Stem Cells Institute Company Information Table 84. Human Stem Cells Institute Business Overview Table 85. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product Portfolio Table 87. Human Stem Cells Institute Recent Development Table 88. Gilead Sciences Company Information Table 89. Gilead Sciences Business Overview Table 90. Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Gilead Sciences Gene-based Advanced Therapy Medical Product Product Portfolio Table 92. Gilead Sciences Recent Development Table 93. bluebird bio Company Information Table 94. bluebird bio Business Overview Table 95. bluebird bio Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. bluebird bio Gene-based Advanced Therapy Medical Product Product Portfolio Table 97. bluebird bio Recent Development Table 98. Biogen Company Information Table 99. Biogen Business Overview Table 100. Biogen Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Biogen Gene-based Advanced Therapy Medical Product Product Portfolio Table 102. Biogen Recent Development Table 103. AnGes Company Information Table 104. AnGes Business Overview Table 105. AnGes Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. AnGes Gene-based Advanced Therapy Medical Product Product Portfolio Table 107. AnGes Recent Development Table 108. Alnylam Pharmaceuticals Company Information Table 109. Alnylam Pharmaceuticals Business Overview Table 110. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product Portfolio Table 112. Alnylam Pharmaceuticals Recent Development Table 113. Akcea Therapeutics Company Information Table 114. Akcea Therapeutics Business Overview Table 115. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio Table 117. Akcea Therapeutics Recent Development Table 118. North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2026) Table 121. North America Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Gene-based Advanced Therapy Medical Product Market Share Forecast by Country (2027-2032) Table 123. Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2026) Table 126. Europe Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Gene-based Advanced Therapy Medical Product Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2026) Table 131. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share Forecast by Country (2027-2032) Table 133. Latin America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2026) Table 136. Latin America Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Gene-based Advanced Therapy Medical Product Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2026) Table 141. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Gene-based Advanced Therapy Medical Product Product Image Figure 3. Global Gene-based Advanced Therapy Medical Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Gene-based Advanced Therapy Medical Product Market Size (2021-2032) & (US$ Million) Figure 5. Global Gene-based Advanced Therapy Medical Product Market Share by Region: 2025 VS 2032 Figure 6. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2021-2032) Figure 7. North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Viral Gene Delivery System Image Figure 13. Global Viral Gene Delivery System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-viral Gene Delivery System Image Figure 15. Global Non-viral Gene Delivery System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Gene-based Advanced Therapy Medical Product Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Gene-based Advanced Therapy Medical Product Market Share by Type 2025 VS 2032 Figure 18. North America Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2032) Figure 19. Europe Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2032) Figure 21. Latin America Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Share by Type (2021-2032) Figure 23. Neurological Diseases Image Figure 24. Global Neurological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Cancer Image Figure 26. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Gene-based Advanced Therapy Medical Product Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gene-based Advanced Therapy Medical Product Market Share by Application 2025 VS 2032 Figure 31. North America Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2032) Figure 32. Europe Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2032) Figure 34. Latin America Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Gene-based Advanced Therapy Medical Product Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Gene-based Advanced Therapy Medical Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Gene-based Advanced Therapy Medical Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2032) Figure 41. Europe Gene-based Advanced Therapy Medical Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Gene-based Advanced Therapy Medical Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2032) Figure 44. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2032) Figure 47. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Gene-based Advanced Therapy Medical Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2032) Figure 50. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Delivery System
  • Non-viral Gene Delivery System
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Novartis
  • Amgen
  • Sunway Biotech
  • Spark Therapeutics
  • SIBIONO
  • Sarepta Therapeutics
  • Orchard Therapeutics
  • Human Stem Cells Institute
  • Gilead Sciences
  • bluebird bio
  • Biogen
  • AnGes
  • Alnylam Pharmaceuticals
  • Akcea Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Gene-based Advanced Therapy Medical Product Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Gene-based Advanced Therapy Medical Product Market Size by Region (2021-2032)
  5. 1.4.1 Global Gene-based Advanced Therapy Medical Product Market Size by Region (2021-2026)
  6. 1.4.2 Global Gene-based Advanced Therapy Medical Product Market Size by Region (2027-2032)
  7. 1.5 Key Regions Gene-based Advanced Therapy Medical Product Market Size (2021-2032)
  8. 1.5.1 North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate (2021-2032)
2 Gene-based Advanced Therapy Medical Product Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Viral Gene Delivery System
  3. 2.1.2 Non-viral Gene Delivery System
  4. 2.2 Global Gene-based Advanced Therapy Medical Product Market Size by Type
  5. 2.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Gene-based Advanced Therapy Medical Product Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Gene-based Advanced Therapy Medical Product Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Gene-based Advanced Therapy Medical Product Market Size by Regions
  9. 2.3.1 North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Type (2021-2026)
3 Gene-based Advanced Therapy Medical Product Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Neurological Diseases
  3. 3.1.2 Cancer
  4. 3.1.3 Other
  5. 3.2 Global Gene-based Advanced Therapy Medical Product Market Size by Application
  6. 3.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Gene-based Advanced Therapy Medical Product Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Gene-based Advanced Therapy Medical Product Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Gene-based Advanced Therapy Medical Product Market Size by Regions
  10. 3.3.1 North America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Gene-based Advanced Therapy Medical Product Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Gene-based Advanced Therapy Medical Product Industry Trends
  2. 4.2 Gene-based Advanced Therapy Medical Product Industry Drivers
  3. 4.3 Gene-based Advanced Therapy Medical Product Industry Opportunities and Challenges
  4. 4.4 Gene-based Advanced Therapy Medical Product Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Gene-based Advanced Therapy Medical Product Revenue (2021-2026)
  2. 5.2 Global Gene-based Advanced Therapy Medical Product Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Gene-based Advanced Therapy Medical Product Key Company Headquarters & Area Served
  4. 5.4 Global Gene-based Advanced Therapy Medical Product Company, Product Type & Application
  5. 5.5 Global Gene-based Advanced Therapy Medical Product Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Gene-based Advanced Therapy Medical Product Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Gene-based Advanced Therapy Medical Product Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Gene-based Advanced Therapy Medical Product Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Gene-based Advanced Therapy Medical Product Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Gene-based Advanced Therapy Medical Product Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Sunway Biotech
  14. 6.3.1 Sunway Biotech Company Information
  15. 6.3.2 Sunway Biotech Business Overview
  16. 6.3.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sunway Biotech Gene-based Advanced Therapy Medical Product Product Portfolio
  18. 6.3.5 Sunway Biotech Recent Developments
  19. 6.4 Spark Therapeutics
  20. 6.4.1 Spark Therapeutics Company Information
  21. 6.4.2 Spark Therapeutics Business Overview
  22. 6.4.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Spark Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio
  24. 6.4.5 Spark Therapeutics Recent Developments
  25. 6.5 SIBIONO
  26. 6.5.1 SIBIONO Company Information
  27. 6.5.2 SIBIONO Business Overview
  28. 6.5.3 SIBIONO Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 SIBIONO Gene-based Advanced Therapy Medical Product Product Portfolio
  30. 6.5.5 SIBIONO Recent Developments
  31. 6.6 Sarepta Therapeutics
  32. 6.6.1 Sarepta Therapeutics Company Information
  33. 6.6.2 Sarepta Therapeutics Business Overview
  34. 6.6.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio
  36. 6.6.5 Sarepta Therapeutics Recent Developments
  37. 6.7 Orchard Therapeutics
  38. 6.7.1 Orchard Therapeutics Company Information
  39. 6.7.2 Orchard Therapeutics Business Overview
  40. 6.7.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio
  42. 6.7.5 Orchard Therapeutics Recent Developments
  43. 6.8 Human Stem Cells Institute
  44. 6.8.1 Human Stem Cells Institute Company Information
  45. 6.8.2 Human Stem Cells Institute Business Overview
  46. 6.8.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product Portfolio
  48. 6.8.5 Human Stem Cells Institute Recent Developments
  49. 6.9 Gilead Sciences
  50. 6.9.1 Gilead Sciences Company Information
  51. 6.9.2 Gilead Sciences Business Overview
  52. 6.9.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Gilead Sciences Gene-based Advanced Therapy Medical Product Product Portfolio
  54. 6.9.5 Gilead Sciences Recent Developments
  55. 6.10 bluebird bio
  56. 6.10.1 bluebird bio Company Information
  57. 6.10.2 bluebird bio Business Overview
  58. 6.10.3 bluebird bio Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 bluebird bio Gene-based Advanced Therapy Medical Product Product Portfolio
  60. 6.10.5 bluebird bio Recent Developments
  61. 6.11 Biogen
  62. 6.11.1 Biogen Company Information
  63. 6.11.2 Biogen Business Overview
  64. 6.11.3 Biogen Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Biogen Gene-based Advanced Therapy Medical Product Product Portfolio
  66. 6.11.5 Biogen Recent Developments
  67. 6.12 AnGes
  68. 6.12.1 AnGes Company Information
  69. 6.12.2 AnGes Business Overview
  70. 6.12.3 AnGes Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 AnGes Gene-based Advanced Therapy Medical Product Product Portfolio
  72. 6.12.5 AnGes Recent Developments
  73. 6.13 Alnylam Pharmaceuticals
  74. 6.13.1 Alnylam Pharmaceuticals Company Information
  75. 6.13.2 Alnylam Pharmaceuticals Business Overview
  76. 6.13.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product Portfolio
  78. 6.13.5 Alnylam Pharmaceuticals Recent Developments
  79. 6.14 Akcea Therapeutics
  80. 6.14.1 Akcea Therapeutics Company Information
  81. 6.14.2 Akcea Therapeutics Business Overview
  82. 6.14.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product Portfolio
  84. 6.14.5 Akcea Therapeutics Recent Developments
7 North America
  1. 7.1 North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026)
  3. 7.3 North America Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026)
  3. 8.3 Europe Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026)
  3. 10.3 South America Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst